patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Free
Message: question to Craig Bird and his answer below on recent pps decline

Who's putting all the pressure on PSTI's stock?  LOL!!!

Any biotech company that doesn't have any income and just went through a reverse split is going to experience downward pressure on the NAZ - "A LOT" OF DOWNWARD PRESSURE! 

 This is why we were hoping that the company was "ready" for their move to the NAZ.

Share
New Message
Please login to post a reply